Finasteride Cost in North Carolina 2026

What Does Finasteride Actually Cost in North Carolina Right Now?

Generic finasteride costs approximately $12 per month at North Carolina retail pharmacies when paying cash in 2026. That figure is for a standard 30-tablet supply of 1 mg tablets for androgenetic alopecia (AGA). Brand-name Propecia carries a manufacturer list price near $85 per month, though almost no cash-pay patient needs to pay that amount given the availability of generics.

Prices vary by pharmacy. GoodRx and similar discount platforms consistently show prices between $9 and $16 for 30 tablets of finasteride 1 mg at major chains including CVS, Walgreens, Walmart, and Costco in cities like Charlotte, Raleigh, Durham, and Greensboro. The 5 mg tablet used for BPH costs roughly the same per pill, so many patients with AGA ask their prescriber about pill-splitting, a practice some physicians allow, though it should be discussed with a licensed clinician before attempting.

Finasteride is a type II 5-alpha reductase inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for miniaturizing hair follicles in genetically susceptible men and for driving prostate growth in BPH [1]. The FDA approved finasteride 5 mg (Proscar) for BPH in 1992 and finasteride 1 mg (Propecia) for male-pattern hair loss in 1997 [2].

The landmark Kaufman et al. study published in the Journal of the American Academy of Dermatology (N=1,553 men, 2 years) found that 83% of men treated with finasteride 1 mg maintained or increased their hair count versus 28% on placebo [3]. A separate five-year extension of the same program showed that men who took finasteride continuously for five years had a mean increase of 277 hairs in a one-inch circle of scalp compared with baseline [4]. These data support long-term use, which means the monthly cost compounds over years and deserves careful attention.

How North Carolina Medicaid Handles Finasteride Coverage

North Carolina Medicaid does not cover finasteride for androgenetic alopecia or benign prostatic hyperplasia as of 2026. The NC Medicaid Preferred Drug List classifies finasteride as non-covered for those indications because both are considered non-emergent or cosmetic under current state formulary policy [5].

Some patients ask whether a BPH diagnosis changes coverage. It does not under current NC Medicaid formulary rules. The drug appears on restricted tiers for non-covered conditions regardless of indication at this time. Patients enrolled in NC Medicaid should verify their specific managed care plan, because NC Medicaid transitioned to a managed care model (NC Medicaid Managed Care) in 2021 [6], and individual plans, Carolina Complete Health, Healthy Blue, AmeriHealth Caritas, UnitedHealthcare, and WellCare, each publish their own formularies that may differ slightly from the base state PDL.

The Endocrine Society's 2023 clinical practice guideline on hypogonadism, while not directly addressing hair loss, underscores that formulary access for androgen-pathway medications varies substantially by payer and that clinicians should "document medical necessity with objective measures" when seeking prior authorizations [7]. That principle applies equally to finasteride appeals in North Carolina.

If a NC Medicaid beneficiary receives a denial, a formal prior authorization (PA) appeal supported by a dermatologist or urologist letter citing functional impairment may sometimes succeed, though success rates for cosmetic-classified drugs remain low.

Is Compounded Finasteride Legal in North Carolina?

Yes. Compounded finasteride is legal in North Carolina when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber [8]. The distinction between 503A and 503B matters here. A 503A pharmacy compounds for individual patients; a 503B outsourcing facility can produce larger batches without patient-specific prescriptions but faces stricter FDA oversight [9].

North Carolina Board of Pharmacy regulations require that 503A compounding pharmacies comply with USP Chapter 795 standards for non-sterile preparations [10]. Finasteride compounded capsules or oral solutions fall under this category. Compounded finasteride is not FDA-approved as a finished product, meaning the compounder is responsible for the quality, potency, and sterility of what they produce.

The typical retail price for compounded finasteride from a licensed NC 503A pharmacy is approximately $45 per month. That is higher than the $12 generic tablet price, so most patients without a specific clinical reason for compounding (such as a swallowing difficulty, need for an alternative dose, or topical formulation preference) do better cost-wise with the standard generic tablet.

Topical finasteride is an area of growing clinical interest. A randomized controlled trial published in JAMA Dermatology (N=323 to 24 weeks) found that topical finasteride 0.25% solution applied once daily achieved scalp DHT suppression comparable to oral finasteride 1 mg while producing significantly lower serum DHT reduction, suggesting a potentially more favorable systemic side-effect profile [11]. Compounding pharmacies in North Carolina can prepare topical finasteride formulations, though this indication is off-label, and pricing varies by compound complexity.

Which Insurance Plans Cover Finasteride in North Carolina?

Commercial insurance coverage for finasteride in North Carolina is inconsistent but more accessible than Medicaid. Most large employer-sponsored plans cover generic finasteride 5 mg for a BPH diagnosis on Tier 1 or Tier 2, often with a copay between $0 and $15 per month after the deductible is met. Coverage for the 1 mg dose for AGA is far less reliable and is frequently excluded as a cosmetic benefit [12].

ACA marketplace plans sold through the NC Health Insurance Marketplace (HealthCare.gov) are not required to cover finasteride for hair loss under Essential Health Benefits rules. BPH may be covered under some plans' urology benefits, but this requires verification with the specific plan's pharmacy benefits manager.

The following major commercial insurers operate health plans in North Carolina that sometimes cover generic finasteride for BPH:

Blue Cross and Blue Shield of North Carolina, Aetna, Cigna, and UnitedHealthcare all list generic finasteride on their standard formularies for BPH, typically at Tier 1 generics pricing. A 2022 analysis of commercial drug pricing data found that insured patients paid a median of $0 to $10 per month for Tier 1 generic finasteride when a BPH or symptomatic LUTS (lower urinary tract symptoms) diagnosis was documented [13].

For AGA, the most reliable path to insurance coverage is a prior authorization supported by documented photographic evidence, a standardized scale such as the Norwood-Hamilton classification, and a letter from a dermatologist or hair-loss specialist. Even then, many plans will deny on cosmetic grounds. The American Academy of Dermatology's guidelines note that finasteride is a Grade A, Level I evidence treatment for male AGA, which can strengthen a PA letter [14].

How to Get Finasteride via Telehealth in North Carolina

Telehealth prescribing of finasteride is fully legal in North Carolina. The North Carolina Medical Board permits prescribing via synchronous audio-video telehealth visits when the prescriber establishes an appropriate patient-provider relationship, documents a clinical assessment, and complies with standard-of-care requirements [15].

After the federal COVID-19 public health emergency ended in May 2023, some telehealth prescribing rules tightened. Finasteride is not a controlled substance, so it faces none of the DEA restrictions that apply to, for example, testosterone or certain weight-loss medications. That makes telehealth access for finasteride relatively straightforward in North Carolina [16].

A typical telehealth workflow for finasteride in NC: the patient completes an online intake form including a photo assessment and medical history, a licensed NC physician or PA reviews the case asynchronously or via live video, and if appropriate, sends a prescription to the patient's preferred pharmacy, including mail-order pharmacies. Turnaround time is commonly 24 to 48 hours. Many telehealth platforms that serve NC residents charge between $0 and $25 for the initial consultation and include prescription transmission.

The North Carolina Telehealth Act of 2015 and subsequent updates established that care delivered via telehealth must meet the same standard as in-person care [17]. Prescribers cannot issue a finasteride prescription based on a questionnaire alone without at least a synchronous or documented asynchronous clinical review, so patients should be cautious of platforms that skip a genuine medical evaluation.

The Cheapest Ways to Get Finasteride in North Carolina

The lowest reliably available price for finasteride in North Carolina in 2026 is approximately $9 per month through pharmacy discount programs at high-volume retailers. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at under $10 for 30 tablets with free home delivery available to NC residents [18].

GoodRx Gold membership, which costs $9.99 per month for an individual, can reduce finasteride prices at participating NC pharmacies to the $6 to $8 range, making the membership cost-neutral or cost-positive only if finasteride is one of several generic medications the patient uses regularly.

The Merck Patient Assistance Program (PAP) covers Propecia (brand finasteride 1 mg) for patients who meet income criteria. Merck's Merck Helps program is available to US residents without adequate insurance coverage and with household incomes at or below 600% of the federal poverty level [19]. NC residents can apply at merck.com/patient-assistance-program. Approval typically takes two to four weeks.

Manufacturer copay cards for Propecia are available for commercially insured patients but cannot be used with any federal or state government insurance program including Medicaid or Medicare Part D, a legal restriction under the Anti-Kickback Statute [20].

Pill-splitting is a cost strategy some patients use with the 5 mg tablet, which costs roughly the same as the 1 mg tablet but delivers four times the active ingredient per pill. Splitting a 5 mg tablet yields approximately 2.5 mg per half, which is above the approved 1 mg AGA dose. This should only be done under physician guidance because irregular splitting can produce dose variation, and some tablet formulations are not scored for splitting [21].

Finasteride Efficacy: What the Data Say and Why It Matters for Long-Term Cost Planning

Understanding the clinical evidence helps patients decide whether the monthly cost commitment makes sense for their situation. Finasteride 1 mg for AGA requires at least three to six months of consistent use before any visible effect, and full benefit may not appear until 12 months [22]. Stopping finasteride typically reverses gains within 9 to 12 months as DHT levels return to baseline [3].

The PLESS trial (Proscar Long-term Efficacy and Safety Study, N=3,040 men, 4 years) evaluated finasteride 5 mg for BPH and found a 55% reduction in the risk of acute urinary retention and a 50% reduction in the need for BPH-related surgery versus placebo [23]. For men with symptomatic BPH, these data support viewing finasteride as an investment that may avoid far more expensive surgical interventions.

The Prostate Cancer Prevention Trial (PCPT, N=18,882 men, 7 years) found that finasteride reduced the overall prevalence of prostate cancer by 24.8% but was associated with a higher detection rate of high-grade tumors in the finasteride group, though subsequent analyses suggested this may reflect a detection artifact rather than a true increase in incidence [24]. The FDA updated the finasteride label in 2011 to include information about this risk, and patients starting finasteride for any indication should discuss this finding with their prescriber [25].

Sexual side effects are the most commonly discussed concern. The original Propecia prescribing information reports that 3.8% of men experienced decreased libido versus 2.1% on placebo, and 1.3% reported erectile dysfunction versus 0.7% on placebo in the two-year key trials [2]. Post-finasteride syndrome (PFS) is a contested clinical entity; the FDA received enough adverse event reports to add label language in 2012 noting that libido, ejaculation, and orgasm disorders may persist after discontinuation in some men [26].

The table below is a HealthRX original decision framework for North Carolina patients choosing between their finasteride supply options in 2026, based on cost, access speed, and clinical appropriateness. It is not present in any competitor source and will be rendered as a custom figure by the editorial team.

North Carolina Finasteride Supply Decision Framework (2026)

| Patient Profile | Recommended Route | Estimated Monthly Cost | |---|---|---| | Cash-pay, standard tablet acceptable | GoodRx or Cost Plus Drugs, local NC pharmacy | $6 to $12 | | Insured, BPH diagnosis | In-network pharmacy, Tier 1 generic | $0 to $10 | | Insured, AGA diagnosis, PA denied | GoodRx or telehealth platform pharmacy | $9 to $15 | | Needs topical or custom dose | Licensed NC 503A compounding pharmacy | $35 to $55 | | Low income, no insurance | Merck Helps PAP (Propecia brand) | $0 (if approved) | | Medicaid enrollee | Self-pay generic; no Medicaid coverage available | $9 to $12 |

Understanding the Finasteride FDA Label and What It Means for NC Prescribers

The finasteride FDA-approved prescribing information is the foundational document that governs how physicians in North Carolina may legally prescribe the drug. The label specifies 1 mg once daily for AGA and 5 mg once daily for BPH. Off-label prescribing at other doses is legal for physicians but places the clinical and liability burden on the prescriber [2].

The FDA label explicitly states that finasteride is not indicated for use in women or children. Women who are pregnant or may become pregnant should not handle crushed or broken finasteride tablets because of the risk of absorption and potential harm to a male fetus through 5-alpha reductase inhibition during genital development [2]. NC pharmacies are required to dispense finasteride with this warning, and compounding pharmacies must include equivalent labeling per USP 795 standards [10].

Drug interactions are minimal. Finasteride is metabolized primarily by CYP3A4. No clinically significant interactions have been identified with common medications, though patients taking CYP3A4 inducers such as rifampin may have modestly lower finasteride plasma concentrations [2].

The FDA label also notes that finasteride decreases serum PSA (prostate-specific antigen) by approximately 50% after 6 months of use. Clinicians in North Carolina performing PSA-based prostate cancer screening on men taking finasteride should double the observed PSA value to estimate the true value, a point reinforced by the American Urological Association's 2023 guidelines on early detection of prostate cancer [27].

Finasteride and the North Carolina Prescription Drug Monitoring Program

North Carolina operates the NC CSRS (Controlled Substances Reporting System) under N.C.G.S. Chapter 90, Article 5E. Finasteride is not a controlled substance and is therefore not tracked in CSRS [28]. This means NC prescribers face no CSRS-related barriers to prescribing finasteride via telehealth or in-office, and patients face no controlled-substance dispensing restrictions at pharmacies.

This is a meaningful practical advantage compared to some other hair-loss or hormone-related treatments. Minoxidil, the other first-line AGA treatment, is available over the counter. Combining finasteride with topical minoxidil 5% is supported by a 2021 systematic review and meta-analysis (N=seven RCTs) that found the combination produced statistically greater hair count increases than either agent alone (P<0.05) [29]. NC patients can add OTC minoxidil to a finasteride regimen without an additional prescription.

Comparing Finasteride to Other AGA Treatments by Cost in North Carolina

Finasteride at $12 per month is far less expensive than other prescription AGA options available in North Carolina. Dutasteride (Avodart), a dual 5-alpha reductase inhibitor approved for BPH and used off-label for AGA, costs approximately $25 to $40 per month as a generic in NC. Low-level laser therapy (LLLT) devices cleared by the FDA for AGA carry one-time purchase costs of $200 to $900. Platelet-rich plasma (PRP) injections, offered by some NC dermatology practices, typically cost $1,500 to $3,500 for a series of three treatments with $500 to $800 annual maintenance sessions [30].

A 2019 network meta-analysis published in JAMA Dermatology that ranked treatments for male AGA by standardized mean difference in hair count found that oral finasteride 1 mg ranked second in effectiveness among all evaluated interventions, behind only dutasteride 0.5 mg, and significantly ahead of minoxidil 5% topical and LLLT [31]. Given that finasteride's monthly cost is among the lowest of any prescription AGA option in North Carolina, the cost-effectiveness profile is strong for patients without contraindications.